← Every company

Relmada Therapeutics Inc SEC Filings

What Relmada Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

RLMD overview →
Filings on file
109
since Nov 10, 2016
Warning signs
4
latest Jul 23, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 6, 2026
Results announced
8-K
Read ↗
Aug 6, 2026
Quarterly report
10-Q
Read ↗
May 28, 2026
Shareholder vote
8-K
Read ↗
May 12, 2026
Results announced
8-K
Read ↗
May 12, 2026
Quarterly report
10-Q
Read ↗
Mar 20, 2026
Results announced
8-K
Read ↗
Mar 19, 2026
Annual report
10-K
Read ↗
Mar 9, 2026
Material agreementUnregistered share sale
8-K
Read ↗
Dec 15, 2025
Executive or director change
8-K
Read ↗
Nov 13, 2025
Results announced
8-K
Read ↗
Nov 13, 2025
Quarterly report
10-Q
Read ↗
Nov 5, 2025
Material agreement
8-K
Read ↗
Aug 7, 2025
Results announced
8-K
Read ↗
Aug 7, 2025
Quarterly report
10-Q
Read ↗
Jul 23, 2025
Delisting notice or listing transfer
8-K
Read ↗
Jul 10, 2025
Material agreement
8-K
Read ↗
May 27, 2025
Shareholder vote
8-K
Read ↗
May 12, 2025
Quarterly report
10-Q
Read ↗
May 12, 2025
Auditor change
8-K
Read ↗
Mar 27, 2025
Results announced
8-K
Read ↗
Mar 27, 2025
Annual report
10-K
Read ↗
Mar 26, 2025
Material agreementUnregistered share sale
8-K
Read ↗
Feb 6, 2025
Material agreement
8-K
Read ↗
Jan 27, 2025
Delisting notice or listing transfer
8-K
Read ↗
Jan 6, 2025
Executive or director change
8-K
Read ↗
Nov 7, 2024
Quarterly report
10-Q
Read ↗
Aug 7, 2024
Quarterly report
10-Q
Read ↗
May 30, 2024
Shareholder vote
8-K
Read ↗
May 8, 2024
Quarterly report
10-Q
Read ↗
Mar 19, 2024
Results announced
8-K
Read ↗
Mar 19, 2024
Annual report
10-K
Read ↗
Jan 11, 2024
Executive or director change
8-K
Read ↗
Jan 3, 2024
Executive or director change
8-K
Read ↗
Nov 8, 2023
Quarterly report
10-Q
Read ↗
Nov 8, 2023
Results announced
8-K
Read ↗
Sep 6, 2023
Executive or director change
8-K
Read ↗
Aug 8, 2023
Results announced
8-K
Read ↗
Aug 8, 2023
Quarterly report
10-Q
Read ↗
May 25, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 11, 2023
Results announced
8-K
Read ↗
May 11, 2023
Quarterly report
10-Q
Read ↗
Mar 23, 2023
Annual report
10-K
Read ↗
Mar 23, 2023
Results announced
8-K
Read ↗
Jan 17, 2023
Executive or director changeMaterial agreement
8-K
Read ↗
Jan 5, 2023
Material agreement
8-K
Read ↗
Dec 28, 2022
Material agreement
8-K
Read ↗
Nov 10, 2022
Results announced
8-K
Read ↗
Nov 10, 2022
Quarterly report
10-Q
Read ↗
Sep 22, 2022
Material agreementUnregistered share sale
8-K
Read ↗
Aug 11, 2022
Quarterly report
10-Q
Read ↗
Jun 1, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 5, 2022
Results announced
8-K
Read ↗
May 5, 2022
Quarterly report
10-Q
Read ↗
Mar 25, 2022
Annual report
10-K
Read ↗
Mar 23, 2022
Results announced
8-K
Read ↗
Dec 13, 2021
Material agreement
8-K
Read ↗
Nov 12, 2021
Quarterly report
10-Q
Read ↗
Aug 10, 2021
Quarterly report
10-Q
Read ↗
Jul 20, 2021
Material agreement
8-K
Read ↗
May 20, 2021
Executive or director changeShareholder vote
8-K
Read ↗
May 12, 2021
Quarterly report
10-Q
Read ↗
Mar 24, 2021
Annual report
10-K
Read ↗
Mar 23, 2021
Results announced
8-K
Read ↗
Jan 5, 2021
Executive or director change
8-K
Read ↗
Nov 12, 2020
Quarterly report
10-Q
Read ↗
Aug 12, 2020
Quarterly report
10-Q
Read ↗
May 15, 2020
Quarterly report
10-Q
Read ↗
Apr 6, 2020
Executive or director change
8-K/A
Read ↗
Mar 26, 2020
Annual report
10-KT
Read ↗
Mar 12, 2020
Executive or director changeMaterial agreement
8-K
Read ↗
Mar 9, 2020
Material agreementShareholder vote
8-K
Read ↗
Jan 10, 2020
Executive or director changeMaterial agreement
8-K
Read ↗
Dec 26, 2019
Executive or director change
8-K
Read ↗
Dec 6, 2019
Material agreement
8-K
Read ↗
Dec 3, 2019
Material agreement
8-K
Read ↗
Nov 13, 2019
Quarterly report
10-Q
Read ↗
Sep 24, 2019
Annual report
10-K
Read ↗
Aug 12, 2019
Share offering
S-1
Read ↗
Jul 29, 2019
Executive or director changeMaterial agreement
8-K
Read ↗
Jun 20, 2019
Material agreementUnregistered share sale
8-K
Read ↗
May 15, 2019
Quarterly report
10-Q
Read ↗
Apr 15, 2019
Material agreement
8-K
Read ↗
Feb 28, 2019
Shareholder vote
8-K
Read ↗
Feb 13, 2019
Quarterly report
10-Q
Read ↗
Feb 11, 2019
Material agreement
8-K
Read ↗
Jan 14, 2019
Share offering
S-1
Read ↗
Jan 4, 2019
Material agreement
8-K
Read ↗
Dec 10, 2018
Material agreementUnregistered share sale
8-K
Read ↗
Nov 13, 2018
Quarterly report
10-Q
Read ↗
Nov 8, 2018
Material agreementUnregistered share sale
8-K
Read ↗
Oct 18, 2018
Material agreementUnregistered share sale
8-K
Read ↗
Sep 28, 2018
Annual report
10-K
Read ↗
Aug 17, 2018
Auditor change
8-K
Read ↗
May 14, 2018
Quarterly report
10-Q
Read ↗
Apr 2, 2018
Executive or director changeMaterial agreement
8-K
Read ↗
Feb 12, 2018
Quarterly report
10-Q
Read ↗
Feb 5, 2018
Shareholder vote
8-K
Read ↗
Jan 19, 2018
Material agreement
8-K
Read ↗
Nov 14, 2017
Quarterly report
10-Q
Read ↗
Oct 4, 2017
Material agreementUnregistered share sale
8-K
Read ↗
Sep 28, 2017
Annual report
10-K
Read ↗
Jun 15, 2017
Material agreement
8-K
Read ↗
Jun 8, 2017
Executive or director changeMaterial agreement
8-K
Read ↗
May 15, 2017
Quarterly report
10-Q
Read ↗
Apr 27, 2017
Executive or director change
8-K
Read ↗
Feb 17, 2017
Executive or director change
8-K
Read ↗
Feb 10, 2017
Quarterly report
10-Q
Read ↗
Feb 1, 2017
Shareholder vote
8-K
Read ↗
Nov 10, 2016
Quarterly report
10-Q
Read ↗

Source: Relmada Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on RLMD

Related datasets